Mable Pereira
Mable Pereira has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Husna Irfan Thalib
Batterjee Medical College
8 shared publications - Sariya Khan
General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia
6 shared publications - Agata Grochowska
Department of General and Transplant Surgery, Medical University of Lodz, Łódź, Poland
2 shared publications - Ancy Jenil Franco
Department of Medicine, Sri Muthukumaran Medical College Hospital and Research Institute, Chennai, Tamil Nadu, India (A.J.-F.).
2 shared publications - Fatma ElSayed Hassan
Department of Physiology, General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia
2 shared publications - Manal El Said
General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia, bmc.edu.sa
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (4) , e70395
Understanding the Gaps in Home Medication Safety: A Cross‐Sectional Study of Knowledge, Attitudes, and Behavioral Determinants
Introduction: Home‐based medication use is common in the management of both acute and chronic health conditions. In Saudi Arabia, factors, such as education level, social background, and health literacy, may influence how medications are stored, used, and managed at home, thereby affecting medication safety. Previous studies have reported gaps in public knowledge, attitudes, and behaviors related to medication safety, including inappropriate use, storage, and adherence practices. Understanding these gaps within the community context is essential for improving safe medication use and reducing medication‐related harm. Aim: This study aims to assess these gaps among adults in Jeddah and suggest ways to improve safety and health outcomes. Methods: This cross‐sectional study was conducted in Jeddah, Saudi Arabia, between December 2023 and March 2024. A community‐based, self‐administered electronic questionnaire was used to assess adults’ knowledge, attitudes, and behaviors regarding home medication safety. The questionnaire consisted of closed‐ended items, including multiple‐choice questions. Convenience sampling was used, and ethical approval was obtained from the Institutional Review Board of Batterjee Medical College. Data analysis was conducted using IBM SPSS Version 25. Results: A total of 312 community‐dwelling adults from Jeddah, Saudi Arabia, participated (mean age 29.6 years), with the majority being female (69.2%), single (61.9%), and college‐educated (56.1%). Most participants reported taking two or fewer medications daily (82.1%) and once per day (75%). Mean scores were highest for medication safety knowledge (68.66%), followed by behavior (65.42%), whereas attitude scores were lowest (53.82%). Female participants had significantly higher knowledge scores than males ( p < 0.0001), and higher medication counts were associated with lower knowledge and poorer behavior ( p < 0.0001). Conclusion: The study highlights key gaps in how adults in Jeddah understand and manage medication at home. More awareness and educational efforts are needed to improve knowledge, encourage safer practices, and positively shift attitudes around medication use.
- 5 October 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (4) , e70395
Open AccessUnderstanding the Gaps in Home Medication Safety: A Cross‐Sectional Study of Knowledge, Attitudes, and Behavioral Determinants
Introduction: Home‐based medication use is common in the management of both acute and chronic health conditions. In Saudi Arabia, factors, such as education level, social background, and health literacy, may influence how medications are stored, used, and managed at home, thereby affecting medication safety. Previous studies have reported gaps in public knowledge, attitudes, and behaviors related to medication safety, including inappropriate use, storage, and adherence practices. Understanding these gaps within the community context is essential for improving safe medication use and reducing medication‐related harm. Aim: This study aims to assess these gaps among adults in Jeddah and suggest ways to improve safety and health outcomes. Methods: This cross‐sectional study was conducted in Jeddah, Saudi Arabia, between December 2023 and March 2024. A community‐based, self‐administered electronic questionnaire was used to assess adults’ knowledge, attitudes, and behaviors regarding home medication safety. The questionnaire consisted of closed‐ended items, including multiple‐choice questions. Convenience sampling was used, and ethical approval was obtained from the Institutional Review Board of Batterjee Medical College. Data analysis was conducted using IBM SPSS Version 25. Results: A total of 312 community‐dwelling adults from Jeddah, Saudi Arabia, participated (mean age 29.6 years), with the majority being female (69.2%), single (61.9%), and college‐educated (56.1%). Most participants reported taking two or fewer medications daily (82.1%) and once per day (75%). Mean scores were highest for medication safety knowledge (68.66%), followed by behavior (65.42%), whereas attitude scores were lowest (53.82%). Female participants had significantly higher knowledge scores than males ( p < 0.0001), and higher medication counts were associated with lower knowledge and poorer behavior ( p < 0.0001). Conclusion: The study highlights key gaps in how adults in Jeddah understand and manage medication at home. More awareness and educational efforts are needed to improve knowledge, encourage safer practices, and positively shift attitudes around medication use.
- 14 July 2026
- Published by Springer Nature
- p. 295-307
Gastrointestinal Injuries: When and How?
- Open Access
- 6 June 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (2) , e70293
Knowledge, Attitude, and Perception of Medical Students Toward AI‐Based Learning: A Cross‐Sectional Study
Background: Artificial intelligence (AI) is rapidly transforming healthcare delivery and medical education. Despite its growing global presence, little is known about the knowledge, attitudes, and perceptions (KAP) of medical students in Pakistan regarding AI‐based learning. Understanding these factors is essential for guiding curriculum development and preparing future physicians for an AI‐driven health system. Objective: To assess the KAP of medical students in Khyber Pakhtunkhwa (KP), Pakistan, toward AI‐based learning. Methods: A cross‐sectional survey was conducted among 392 medical students from multiple medical colleges in KP. A structured, self‐administered questionnaire was used to assess KAP toward AI‐based learning. Data were analyzed using SPSS version 26, employing descriptive statistics and chi‐square tests to examine group differences. Ordinal logistic regression was performed to identify independent predictors, with statistical significance set at p < 0.05. Ethical approval was obtained from the Institutional Review Board of Gomal Medical College, and informed consent was obtained from all participants. Results: Of the 392 participants, most demonstrated moderate knowledge (62.8%) regarding AI‐based learning, whereas only 30.4% achieved high knowledge scores. Significant variation was observed across academic years, with senior students demonstrating greater knowledge than preclinical students ( p < 0.05). In contrast, attitudes and perceptions were largely positive across all years, with nearly three‐quarters (74.8%) of students expressing favorable views toward AI. Only 0.8% reported negative attitudes. These findings suggest that enthusiasm for AI is high, but comprehensive understanding remains limited. Conclusion: Medical students in KP exhibit strong enthusiasm and positive perceptions toward AI‐based learning, yet their knowledge remains modest and uneven across training levels. This mismatch highlights the urgent need for structured AI education in undergraduate curricula. Incorporating formal training, workshops, and faculty development programs can bridge this gap and better prepare future physicians to responsibly integrate AI into clinical practice.
- 6 June 2026
- Published by Wiley in Public Health Challenges
- Vol. 5 (2) , e70293
Open AccessKnowledge, Attitude, and Perception of Medical Students Toward AI‐Based Learning: A Cross‐Sectional Study
Background: Artificial intelligence (AI) is rapidly transforming healthcare delivery and medical education. Despite its growing global presence, little is known about the knowledge, attitudes, and perceptions (KAP) of medical students in Pakistan regarding AI‐based learning. Understanding these factors is essential for guiding curriculum development and preparing future physicians for an AI‐driven health system. Objective: To assess the KAP of medical students in Khyber Pakhtunkhwa (KP), Pakistan, toward AI‐based learning. Methods: A cross‐sectional survey was conducted among 392 medical students from multiple medical colleges in KP. A structured, self‐administered questionnaire was used to assess KAP toward AI‐based learning. Data were analyzed using SPSS version 26, employing descriptive statistics and chi‐square tests to examine group differences. Ordinal logistic regression was performed to identify independent predictors, with statistical significance set at p < 0.05. Ethical approval was obtained from the Institutional Review Board of Gomal Medical College, and informed consent was obtained from all participants. Results: Of the 392 participants, most demonstrated moderate knowledge (62.8%) regarding AI‐based learning, whereas only 30.4% achieved high knowledge scores. Significant variation was observed across academic years, with senior students demonstrating greater knowledge than preclinical students ( p < 0.05). In contrast, attitudes and perceptions were largely positive across all years, with nearly three‐quarters (74.8%) of students expressing favorable views toward AI. Only 0.8% reported negative attitudes. These findings suggest that enthusiasm for AI is high, but comprehensive understanding remains limited. Conclusion: Medical students in KP exhibit strong enthusiasm and positive perceptions toward AI‐based learning, yet their knowledge remains modest and uneven across training levels. This mismatch highlights the urgent need for structured AI education in undergraduate curricula. Incorporating formal training, workshops, and faculty development programs can bridge this gap and better prepare future physicians to responsibly integrate AI into clinical practice.
- Open Access
- 29 May 2026
- Published by Wolters Kluwer Health in Formosan Journal of Surgery
Effect of Prehabilitation with GLP-1 Agonists in Obese Patients Undergoing Abdominal Wall Reconstruction or Complex Hernia Repair: A Scoping Review
Background: Obesity is a well-established risk factor for hernia development, recurrence, and adverse perioperative outcomes, posing major challenges in patients undergoing abdominal wall reconstruction (AWR) or complex hernia repair (CHR). Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially approved for type 2 diabetes, have demonstrated substantial weight-loss benefits and are increasingly used for preoperative optimization. Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted for studies published up to June 11, 2025, evaluating GLP-1RA use in obese adults undergoing AWR or CHR. Studies were selected using predefined criteria. Data were charted and synthesized thematically to assess preoperative weight loss, time to surgery, perioperative safety, wound complications, and feasibility. Results: Three observational studies including 65 obese patients undergoing AWR or CHR were identified. GLP-1RA use was associated with a shorter time to surgery (6.3–9.1 months) compared with controls (13.5–14.7 months) and moderate preoperative weight loss (11.3–14.9%). Thirty-day morbidity was lower or comparable in GLP-1RA groups. Reported adverse events were infrequent, non-serious, and manageable. Conclusion: Preoperative GLP-1RA therapy appears promising as a prehabilitation strategy; however, current evidence is limited to small, heterogeneous observational studies with significant risk of bias. These findings should be considered hypothesis-generating rather than practice-changing.
- 29 May 2026
- Published by Wolters Kluwer Health in Formosan Journal of Surgery
Open AccessEffect of Prehabilitation with GLP-1 Agonists in Obese Patients Undergoing Abdominal Wall Reconstruction or Complex Hernia Repair: A Scoping Review
Background: Obesity is a well-established risk factor for hernia development, recurrence, and adverse perioperative outcomes, posing major challenges in patients undergoing abdominal wall reconstruction (AWR) or complex hernia repair (CHR). Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially approved for type 2 diabetes, have demonstrated substantial weight-loss benefits and are increasingly used for preoperative optimization. Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted for studies published up to June 11, 2025, evaluating GLP-1RA use in obese adults undergoing AWR or CHR. Studies were selected using predefined criteria. Data were charted and synthesized thematically to assess preoperative weight loss, time to surgery, perioperative safety, wound complications, and feasibility. Results: Three observational studies including 65 obese patients undergoing AWR or CHR were identified. GLP-1RA use was associated with a shorter time to surgery (6.3–9.1 months) compared with controls (13.5–14.7 months) and moderate preoperative weight loss (11.3–14.9%). Thirty-day morbidity was lower or comparable in GLP-1RA groups. Reported adverse events were infrequent, non-serious, and manageable. Conclusion: Preoperative GLP-1RA therapy appears promising as a prehabilitation strategy; however, current evidence is limited to small, heterogeneous observational studies with significant risk of bias. These findings should be considered hypothesis-generating rather than practice-changing.
- Open Access
- 14 April 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (4) , e70545
Hemophagocytic Lymphohystiocytosis in a Patient With Suspected Acute Myeloid Leukemia and Recent Viral Illness Compatible With Dengue: A Case Report and Literature Review
Background: Hemophagocytic lymphohistiocytosis, or HLH, is a very rare and aggressive disorder of the immune system, for which the trigger may be an infection, malignancy, or autoimmune disease. It has predominantly been described as triggered by T/NK lymphomas, but acute myeloid leukemia‐induced HLH is a very rare occurrence. Viral infections like dengue fever may act as potential triggering factors. Case Presentation: A 24‐year‐old male developed persistent high fever, weakness, and pancytopenia a few days after recovery following a recent febrile illness clinically compatible with dengue infection in a dengue‐endemic setting, supported by IgG seropositivity (IgM negative). He was found to be reactive for hyperferritinemia, coagulopathy, and hepatopathy. Bone marrow biopsies revealed blasts of 78%, which were suggestive of AML and myelomonocytic differentiation but also reflected abnormalities in the chromosomes t (1;9)(q42;q22), add(11)(q23). Discussion: This is an instance of an extremely rare and critical manifestation of HLH, coinciding with suggestive AML, seemingly triggered by an acute dengue illness. In our literature search, there were a few instances of AML and HLH, either preceding AML, concurrent, or post‐AML, mainly in younger individuals with high‐risk cytogenetics and an aggressive disease course. Generally, the prognosis in these instances turned out to be poor, mainly for those who experienced a delay in diagnosis and management or those complicated with infections and chemotherapy. In the given scenario, the patient suffered from severe complications in the initial stage, including disseminated intravascular coagulation, but responded to supportive care, and his clinical condition was stabilized. Later, the patient was shifted to a referral institute for management, and further prognosis information was not obtained. Conclusion: This particular case illustrates the importance of considering the possibility of HLH in the setting of unexplained systemic inflammation with the presence of an identified hematologic malignancy and preceding infection by a virus. However, the prognosis for patients with concomitant diagnoses of both HLH and AML is not encouraging.
- 14 April 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (4) , e70545
Open AccessHemophagocytic Lymphohystiocytosis in a Patient With Suspected Acute Myeloid Leukemia and Recent Viral Illness Compatible With Dengue: A Case Report and Literature Review
Background: Hemophagocytic lymphohistiocytosis, or HLH, is a very rare and aggressive disorder of the immune system, for which the trigger may be an infection, malignancy, or autoimmune disease. It has predominantly been described as triggered by T/NK lymphomas, but acute myeloid leukemia‐induced HLH is a very rare occurrence. Viral infections like dengue fever may act as potential triggering factors. Case Presentation: A 24‐year‐old male developed persistent high fever, weakness, and pancytopenia a few days after recovery following a recent febrile illness clinically compatible with dengue infection in a dengue‐endemic setting, supported by IgG seropositivity (IgM negative). He was found to be reactive for hyperferritinemia, coagulopathy, and hepatopathy. Bone marrow biopsies revealed blasts of 78%, which were suggestive of AML and myelomonocytic differentiation but also reflected abnormalities in the chromosomes t (1;9)(q42;q22), add(11)(q23). Discussion: This is an instance of an extremely rare and critical manifestation of HLH, coinciding with suggestive AML, seemingly triggered by an acute dengue illness. In our literature search, there were a few instances of AML and HLH, either preceding AML, concurrent, or post‐AML, mainly in younger individuals with high‐risk cytogenetics and an aggressive disease course. Generally, the prognosis in these instances turned out to be poor, mainly for those who experienced a delay in diagnosis and management or those complicated with infections and chemotherapy. In the given scenario, the patient suffered from severe complications in the initial stage, including disseminated intravascular coagulation, but responded to supportive care, and his clinical condition was stabilized. Later, the patient was shifted to a referral institute for management, and further prognosis information was not obtained. Conclusion: This particular case illustrates the importance of considering the possibility of HLH in the setting of unexplained systemic inflammation with the presence of an identified hematologic malignancy and preceding infection by a virus. However, the prognosis for patients with concomitant diagnoses of both HLH and AML is not encouraging.
- Open Access
- 5 February 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (2) , e71254
Modulating the Gut Microbiome as a Therapeutic Approach in Multiple Sclerosis: Implications for Gut‐Brain Interactions and Immune Pathways: A Narrative Review
Purpose: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by progressive disability. Emerging evidence has implicated gut microbiome dysbiosis, characterized by decreased short‐chain fatty acids (SCFAs)‐producing taxa and increased pro‐inflammatory species, in disturbed immune signaling, T‐helper17/T‐regulatory cells imbalance, disturbed tryptophan metabolism, and disrupted integrity of the blood–brain barrier. In this review, we summarize the mechanistic and therapeutic insights from studies that have explored the gut microbiome in MS. Method: We performed a literature search in PubMed, Scopus, Web of Science, and ClinicalTrials.gov from database inception to January 2025; only English‐language articles were included, comprising human MS cohorts and preclinical experimental autoimmune encephalomyelitis models. Of these, approximately 95 human and preclinical studies fulfilled the inclusion criteria. Evidence synthesis was narrative, without meta‐analysis. Finding: There has been a consistent depletion of beneficial genera such as Faecalibacterium and Roseburia, expansion of Akkermansia muciniphila, and reduction in microbial metabolites such as butyrate, propionate, and neuroactive indole derivatives in MS patients across studies. These changes promote intestinal permeability, exaggerated pro‐inflammatory cytokine responses, and microglial activation. The therapeutic approach of restoring microbial balance includes therapies such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and dietary interventions. Early trials have shown modest improvements in relapse rates, fatigue, immune profiles, and microbiome composition. Results across randomized studies are heterogeneous, with no significant clinical benefit in several. Pilot trials report modest reductions in relapse rate (RR ≈ 0.85) and fatigue (Cohen's d ≈ 0.3), but several double‑blind RCTs showed no significant benefit ( p > 0.05) in up to 40% of participants, highlighting variable effect sizes. Conclusion: Interventions aimed at the microbiome are promising as adjunct approaches to the treatment of MS, acting principally through the restoration of SCFAs, immune modulation, and strengthening of the gut‐brain axis. Larger, longer‐term randomized trials are required to confirm clinical efficacy, define responder phenotypes, and inform personalized microbiome‐based therapies.
- 5 February 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (2) , e71254
Open AccessModulating the Gut Microbiome as a Therapeutic Approach in Multiple Sclerosis: Implications for Gut‐Brain Interactions and Immune Pathways: A Narrative Review
Purpose: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by progressive disability. Emerging evidence has implicated gut microbiome dysbiosis, characterized by decreased short‐chain fatty acids (SCFAs)‐producing taxa and increased pro‐inflammatory species, in disturbed immune signaling, T‐helper17/T‐regulatory cells imbalance, disturbed tryptophan metabolism, and disrupted integrity of the blood–brain barrier. In this review, we summarize the mechanistic and therapeutic insights from studies that have explored the gut microbiome in MS. Method: We performed a literature search in PubMed, Scopus, Web of Science, and ClinicalTrials.gov from database inception to January 2025; only English‐language articles were included, comprising human MS cohorts and preclinical experimental autoimmune encephalomyelitis models. Of these, approximately 95 human and preclinical studies fulfilled the inclusion criteria. Evidence synthesis was narrative, without meta‐analysis. Finding: There has been a consistent depletion of beneficial genera such as Faecalibacterium and Roseburia, expansion of Akkermansia muciniphila, and reduction in microbial metabolites such as butyrate, propionate, and neuroactive indole derivatives in MS patients across studies. These changes promote intestinal permeability, exaggerated pro‐inflammatory cytokine responses, and microglial activation. The therapeutic approach of restoring microbial balance includes therapies such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and dietary interventions. Early trials have shown modest improvements in relapse rates, fatigue, immune profiles, and microbiome composition. Results across randomized studies are heterogeneous, with no significant clinical benefit in several. Pilot trials report modest reductions in relapse rate (RR ≈ 0.85) and fatigue (Cohen's d ≈ 0.3), but several double‑blind RCTs showed no significant benefit ( p > 0.05) in up to 40% of participants, highlighting variable effect sizes. Conclusion: Interventions aimed at the microbiome are promising as adjunct approaches to the treatment of MS, acting principally through the restoration of SCFAs, immune modulation, and strengthening of the gut‐brain axis. Larger, longer‐term randomized trials are required to confirm clinical efficacy, define responder phenotypes, and inform personalized microbiome‐based therapies.
- Top Cited PapersOpen Access
- 29 January 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (2) , e71562
Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility
Introduction: Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (rel/ref) disease. This subgroup has historically faced poor prognoses with limited treatment options, prompting the development of novel immunotherapeutic strategies. Chimeric antigen receptor T‐cell (CAR T) therapy and bispecific antibodies (BsAbs) have emerged as transformative approaches in this setting. Methods: This narrative review compares these therapies across multiple domains, including mechanisms of action, clinical efficacy, safety profiles, logistics, cost, and accessibility. Results: CAR T therapies have demonstrated durable complete response rates (40%–60%) and extended progression‐free survival (median 11–12.5 months), but they are limited by complex manufacturing, high cost, and potentially severe toxicities. In contrast, BsAbs offer immediate, off‐the‐shelf availability, with promising efficacy and a more favorable safety profile that enables outpatient administration, although long‐term durability remains under investigation. Conclusion: This review provides clinicians with a comprehensive comparison to support evidence‐based treatment selection in rel/ref DLBCL.
- 29 January 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (2) , e71562
Top Cited PapersOpen AccessBispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility
Introduction: Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (rel/ref) disease. This subgroup has historically faced poor prognoses with limited treatment options, prompting the development of novel immunotherapeutic strategies. Chimeric antigen receptor T‐cell (CAR T) therapy and bispecific antibodies (BsAbs) have emerged as transformative approaches in this setting. Methods: This narrative review compares these therapies across multiple domains, including mechanisms of action, clinical efficacy, safety profiles, logistics, cost, and accessibility. Results: CAR T therapies have demonstrated durable complete response rates (40%–60%) and extended progression‐free survival (median 11–12.5 months), but they are limited by complex manufacturing, high cost, and potentially severe toxicities. In contrast, BsAbs offer immediate, off‐the‐shelf availability, with promising efficacy and a more favorable safety profile that enables outpatient administration, although long‐term durability remains under investigation. Conclusion: This review provides clinicians with a comprehensive comparison to support evidence‐based treatment selection in rel/ref DLBCL.
- Open Access
- 1 January 2026
- Published by Wiley in Stroke Research and Treatment
- Vol. 2026 (1)
Stereotactic Hematoma Aspiration Versus Standard Treatment for Brainstem Hemorrhage—Updated Meta‐Analysis, Meta‐Regression, and Trial Sequential Analysis
Introduction: The standard treatment of brainstem hemorrhage (BH) remains a controversial subject, and the optimal treatment strategy remains unclear. Stereotactic aspiration of a hematoma is one of the most used techniques in BH management. This review aims to update existing knowledge on the comparison of aspiration and standard treatments for BH. Methods: This review updates a previous meta‐analysis on this subject. Four medical databases were searched from inception, and meta‐analysis was performed with a random‐effects model. Odds ratios (ORs) and mean differences (MDs) were applied for comparison. Results: A total of 15 studies were included in this review. There was a significant reduction in total mortality (OR 0.26, 95% CI 0.17–0.41, p < 0.001), mortality rate at 1‐month follow‐up (OR 0.32, 95% CI 0.22–0.46, p < 0.001), and an increased proportion of patients with mRS ≤ 3 (OR 2.69, 95% CI 1.57–4.59, p < 0.001) in the surgical group compared with standard treatment. Meta‐regression revealed a significant correlation between GCS at admission and total mortality. There was no significant difference in rebleeding, stress ulcers, central hyperthermia, length of hospital stay, or respiratory complications. Trial sequential analysis showed a true‐positive result for mortality. Conclusions: Stereotactic surgery is becoming a promising method for the treatment of BH. The results of this synthesis suggest that patients undergoing invasive treatment have higher survival rates and better functional outcomes compared with usual care. Although stereotactic aspiration yielded a higher survival in the meta‐analysis, quality concerns, false‐positive results for patients with mRS ≤ 3, and heterogeneity need to be acknowledged.
- 1 January 2026
- Published by Wiley in Stroke Research and Treatment
- Vol. 2026 (1)
Open AccessStereotactic Hematoma Aspiration Versus Standard Treatment for Brainstem Hemorrhage—Updated Meta‐Analysis, Meta‐Regression, and Trial Sequential Analysis
Introduction: The standard treatment of brainstem hemorrhage (BH) remains a controversial subject, and the optimal treatment strategy remains unclear. Stereotactic aspiration of a hematoma is one of the most used techniques in BH management. This review aims to update existing knowledge on the comparison of aspiration and standard treatments for BH. Methods: This review updates a previous meta‐analysis on this subject. Four medical databases were searched from inception, and meta‐analysis was performed with a random‐effects model. Odds ratios (ORs) and mean differences (MDs) were applied for comparison. Results: A total of 15 studies were included in this review. There was a significant reduction in total mortality (OR 0.26, 95% CI 0.17–0.41, p < 0.001), mortality rate at 1‐month follow‐up (OR 0.32, 95% CI 0.22–0.46, p < 0.001), and an increased proportion of patients with mRS ≤ 3 (OR 2.69, 95% CI 1.57–4.59, p < 0.001) in the surgical group compared with standard treatment. Meta‐regression revealed a significant correlation between GCS at admission and total mortality. There was no significant difference in rebleeding, stress ulcers, central hyperthermia, length of hospital stay, or respiratory complications. Trial sequential analysis showed a true‐positive result for mortality. Conclusions: Stereotactic surgery is becoming a promising method for the treatment of BH. The results of this synthesis suggest that patients undergoing invasive treatment have higher survival rates and better functional outcomes compared with usual care. Although stereotactic aspiration yielded a higher survival in the meta‐analysis, quality concerns, false‐positive results for patients with mRS ≤ 3, and heterogeneity need to be acknowledged.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Pediatrics
- Vol. 2026 (1) , 7930070
Cognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis
Background: Depression and anxiety occur in about 10% of pregnancies. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed, but their potential effects on fetal neurodevelopment remain uncertain. Because serotonin influences brain maturation, prenatal SSRI exposure may affect later cognition, language, or motor function. Methods: This systematic review and meta‐analysis evaluated whether prenatal SSRI exposure is associated with differences in child cognitive, language, or psychomotor development. PubMed and Scopus were searched through June 2025 for cohort, case‐control, or randomized studies reporting standardized neurodevelopmental outcomes in children (0–18 years) with documented in utero SSRI exposure compared with unexposed controls. Two reviewers independently screened studies, extracted data, and assessed bias (Newcastle–Ottawa Scale; RoB‐2). Random‐effects meta‐analyses estimated standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results: Of 250 records identified, 17 studies met inclusion criteria, and 9 contributed to meta‐analysis. For general cognition, pooled SMD = −0.20 (95% CI −0.50 to 0.10) showed no significant difference between groups. Sensitivity analyses restricted to SSRI‐only cohorts and Bayley‐specific instruments yielded similar findings. Secondary outcomes also showed no differences: receptive language (SMD = 0.04; 95% CI −0.16 to 0.23), expressive language (SMD = −0.17; 95% CI −0.40 to 0.06), and psychomotor development (SMD = −0.18; 95% CI −0.67 to 0.31). Conclusions: Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development. Observed effects were small, imprecise, and diminished when analyses were limited to SSRI‐only cohorts and harmonized outcome measures.
- 1 January 2026
- Published by Wiley in International Journal of Pediatrics
- Vol. 2026 (1) , 7930070
Open AccessCognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis
Background: Depression and anxiety occur in about 10% of pregnancies. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed, but their potential effects on fetal neurodevelopment remain uncertain. Because serotonin influences brain maturation, prenatal SSRI exposure may affect later cognition, language, or motor function. Methods: This systematic review and meta‐analysis evaluated whether prenatal SSRI exposure is associated with differences in child cognitive, language, or psychomotor development. PubMed and Scopus were searched through June 2025 for cohort, case‐control, or randomized studies reporting standardized neurodevelopmental outcomes in children (0–18 years) with documented in utero SSRI exposure compared with unexposed controls. Two reviewers independently screened studies, extracted data, and assessed bias (Newcastle–Ottawa Scale; RoB‐2). Random‐effects meta‐analyses estimated standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results: Of 250 records identified, 17 studies met inclusion criteria, and 9 contributed to meta‐analysis. For general cognition, pooled SMD = −0.20 (95% CI −0.50 to 0.10) showed no significant difference between groups. Sensitivity analyses restricted to SSRI‐only cohorts and Bayley‐specific instruments yielded similar findings. Secondary outcomes also showed no differences: receptive language (SMD = 0.04; 95% CI −0.16 to 0.23), expressive language (SMD = −0.17; 95% CI −0.40 to 0.06), and psychomotor development (SMD = −0.18; 95% CI −0.67 to 0.31). Conclusions: Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development. Observed effects were small, imprecise, and diminished when analyses were limited to SSRI‐only cohorts and harmonized outcome measures.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 8368761
Comparative Effectiveness of Single‐Dose vs. Multi‐Dose Prophylactic Antibiotics in Reducing Post‐Surgical Infections: A Systematic Review and Meta‐Analysis
Background: Surgical site infections (SSIs) are among the most frequent and costly postoperative complications, contributing to increased morbidity, extended hospitalization, and healthcare burden. Although guidelines support single‐dose antibiotic prophylaxis for most surgeries, multi‐dose regimens remain widely used in clinical practice, especially in high‐risk procedures. This review aimed to compare the effectiveness of single‐dose versus multiple‐dose prophylactic antibiotic regimens in preventing postoperative infections. Methods: A systematic review and meta‐analysis were conducted according to PRISMA 2020 guidelines. Databases including PubMed, Scopus, CENTRAL, Web of Science, and ScienceDirect were searched up to February 2025. Studies involving human participants undergoing surgery, comparing single‐ and multiple‐dose antibiotic prophylaxis with infection‐related outcomes, were included. Risk of bias was assessed using the Cochrane RoB 2.0 and MINORS tools. Meta‐analyses were performed using random‐effects models. Results: Forty‐seven studies encompassing various surgical disciplines and patient populations were included. No statistically significant difference in SSI rates was observed between single‐ and multiple‐dose groups (OR: 1.10 [95% CI: 0.87–1.39], p = 0.43). Similarly, no differences were detected for other postoperative infections, mortality, or readmissions. Heterogeneity was moderate to high across analyses. Most studies reported comparable infection outcomes despite differences in antibiotic type, follow‐up duration, and surgical setting. Conclusion: Single‐dose antibiotic prophylaxis is as effective as multiple‐dose regimens in reducing postoperative infections in most surgical contexts. These findings support current recommendations favoring single‐dose administration and reinforce antimicrobial stewardship efforts. Extended prophylaxis should be reserved for selected high‐risk cases rather than routine use.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 8368761
Open AccessComparative Effectiveness of Single‐Dose vs. Multi‐Dose Prophylactic Antibiotics in Reducing Post‐Surgical Infections: A Systematic Review and Meta‐Analysis
Background: Surgical site infections (SSIs) are among the most frequent and costly postoperative complications, contributing to increased morbidity, extended hospitalization, and healthcare burden. Although guidelines support single‐dose antibiotic prophylaxis for most surgeries, multi‐dose regimens remain widely used in clinical practice, especially in high‐risk procedures. This review aimed to compare the effectiveness of single‐dose versus multiple‐dose prophylactic antibiotic regimens in preventing postoperative infections. Methods: A systematic review and meta‐analysis were conducted according to PRISMA 2020 guidelines. Databases including PubMed, Scopus, CENTRAL, Web of Science, and ScienceDirect were searched up to February 2025. Studies involving human participants undergoing surgery, comparing single‐ and multiple‐dose antibiotic prophylaxis with infection‐related outcomes, were included. Risk of bias was assessed using the Cochrane RoB 2.0 and MINORS tools. Meta‐analyses were performed using random‐effects models. Results: Forty‐seven studies encompassing various surgical disciplines and patient populations were included. No statistically significant difference in SSI rates was observed between single‐ and multiple‐dose groups (OR: 1.10 [95% CI: 0.87–1.39], p = 0.43). Similarly, no differences were detected for other postoperative infections, mortality, or readmissions. Heterogeneity was moderate to high across analyses. Most studies reported comparable infection outcomes despite differences in antibiotic type, follow‐up duration, and surgical setting. Conclusion: Single‐dose antibiotic prophylaxis is as effective as multiple‐dose regimens in reducing postoperative infections in most surgical contexts. These findings support current recommendations favoring single‐dose administration and reinforce antimicrobial stewardship efforts. Extended prophylaxis should be reserved for selected high‐risk cases rather than routine use.